Navigation Links
Life Technologies Announces Third Quarter 2013 Results
Date:11/5/2013

prior year.  Excluding the impact of currency, revenue for the business group increased 6 percent primarily due to strong sales from the Company's fluorescent imaging, stem cells, synthetic biology and cell culture products.
  • Genetic Analysis revenue was $338 million in the third quarter, a decrease of 4 percent over the same period last year.  Excluding the impact of currency, revenue decreased 3 percent.  Results for the quarter were primarily driven by an expected decline in qPCR royalties and SOLiD sales, offset by continued solid performance in the rest of the business.
  • Applied Sciences revenue was $194 million in the third quarter, an increase of 12 percent over the prior year.  Excluding the impact of currency, revenue increased 13 percent primarily as a result of an increase in Bioproduction sales.
  • Regional revenue growth rates excluding currency for the third quarter, compared to the same quarter of the prior year, were as follows: the Americas were flat, Europe grew 2 percent, Asia Pacific grew 18 percent, and Japan grew 8 percent.  
  • Outlook
    Given the announcement in April that Life Technologies and Thermo Fisher have entered into a definitive merger agreement under which Thermo Fisher will acquire all of the outstanding shares of Life Technologies for $76.00 per share in cash, the Company is no longer providing quarterly guidance.  The Company will continue to provide commentary regarding the impact that fluctuations in currency rates could have on results. 

    Based on September 30, 2013 rates, currency is expected to have a negative impact of approximately $57 million on revenue and $0.13 on non-GAAP EPS for the full year.  This compares to a negative impact of $75 million on revenue and $0.17 on non-GAAP EPS for the full year at June 30, 2013 rates.

    Conference Calls
    In light of the announced transaction with Thermo Fisher, the Company will no
    '/>"/>

    SOURCE Life Technologies Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
    2. UV Flu Technologies Expands Its International Footprint
    3. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
    4. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
    5. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
    6. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
    7. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
    8. Animal Biotechnology - Technologies, Markets and Companies
    9. Gene Therapy - Technologies, Markets and Companies
    10. Biomarkers - Technologies, Markets and Companies
    11. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... (PRWEB) December 23, 2014 Nashville Fertility ... was elected treasurer for the American Society for Reproductive ... knowledge and research in reproductive medicine. In his ... seat on the executive board and will have a ... Dr. Hill has actively supported ASRM since 1984 when ...
    (Date:12/24/2014)... CA (PRWEB) December 23, 2014 Pipette.com ... where their Twitter followers can submit their #HolidayInTheLab pictures ... and their lab mates. , For those struggling to ... mates, the Pipette.com Holiday in the Lab Contest provides ... Pipette.com Twitter followers to send pictures of their ...
    (Date:12/24/2014)... , Dec. 23, 2014 Vermillion, ... focused on gynecologic disease, announced today that investors ... , Birchview Fund LLC and several Vermillion directors ... unregistered shares of Vermillion,s common stock and warrants ... in a private placement.  Under ...
    (Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich Corporation ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements ... expired on December 22, 2014, thereby completing the ... for the acquisition of the Company by Merck ... clearance satisfies another condition to closing the transaction, ...
    Breaking Biology Technology:Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 2Nashville Fertility Center Announces Dr. George A. Hill Selected to Serve as ASRM Treasurer for 2014-15 3Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3
    ... RIVER, N.J., July 29 PDI, Inc. (Nasdaq: PDII ... U.S. pharmaceutical companies, today announced that it will release its second ... market close. , , PDI will host ... on August 5, 2009 to discuss the results. To participate in ...
    ... BRISBANE, Calif., July 29 InterMune, Inc. (Nasdaq: ITMN ... results on Thursday, August 6, 2009 at 4:00 p.m. Eastern time. ... InterMune at 4:30 p.m. Eastern time that same day. , ... or 973-200-3372 (international), conference ID# 22196018. To access the webcast, ...
    ... , EATONTOWN, N.J., July 29 ... the emerging field of biologic products for regenerative healing, today ... Company, the French regulatory agency, afssaps, rescinded its December 17, ... tissue products processed from donors procured by TB OsteoCentre Bulgaria ...
    Cached Biology Technology:PDI, Inc. to Hold Second Quarter 2009 Financial Results Conference Call on Wednesday, August 5, 2009 2InterMune to Release Second Quarter Financial Results on August 6 2Osteotech Resumes Shipments of Bulgarian Tissue 2Osteotech Resumes Shipments of Bulgarian Tissue 3
    (Date:12/22/2014)... , Dec. 22, 2014 Research ... has announced the addition of the ... report to their offering. ... insight provides an overview of the global ... aims to control and monitor piracy by ...
    (Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal ... that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four ... has served as a meeting place for peoples ... and the ongoing mixing of peoples with African, European, ...
    (Date:12/17/2014)...  HITLAB SM announced today its completion ... confirm its adherence to current U.S. Food and ... to conduct regulated smart device and smart phone ... safety and research quality. "HITLAB is ... delivery with innovative technology," said Laura Pugliese ...
    Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
    ... U.S. Department of Energy (DOE) Joint Genome Institute (JGI) ... winning at the 13th Annual Applied Ergonomics Conference held ... The Ergo Cup highlights ergonomic innovations from institutions and ... in Ergonomics," was for the Ergonomic Program Improvement Initiatives ...
    ... A preliminary study by New Zealand company Plant ... may help breathing in some types of asthma. ... may reduce lung inflammation with a multi-action assault in ... to enhance the natural defence mechanisms in lung tissue ...
    ... Ghoneum today will discuss his findings on cancer research and ... event, sponsored by the Egyptian Cultural and Educational Bureau, will ... reception. Ghoneum, an Egyptian-born researcher and professor at Charles ... been studying natural cures for cancer for more than two ...
    Cached Biology News:Breathe easy: A natural fruit compound may help asthma 2
    Component in MasterPure™ Purification Kits...
    Anti-gp340 Monoclonal Antibody Description: 100 g Research Focus: cancer & cell proliferation Storage: -20C Shipping Temperature: 4C...
    Mouse anti-HIV-Imn PND Class: Antibody Product Group: Bacterial and Viral Antigen...
    ... Product Goat polyclonal to BRF2 Immunogen ... amino acids 406-419 of Human BRF2. Reactivity ... tested in other species. Background Information ... the RNA polymerase III transcription factor complex required ...
    Biology Products: